Heartflow raises $364.2 million in upsized IPO at $19 per share

Published 11/08/2025, 21:38
Heartflow raises $364.2 million in upsized IPO at $19 per share

MOUNTAIN VIEW, Calif. - Heartflow, Inc. (NASDAQ:HTFL), an AI technology company focused on coronary artery disease, announced Monday it has closed its initial public offering after raising approximately $364.2 million in gross proceeds.

The company sold 19,166,667 shares of common stock at $19 per share, which included 2,500,000 additional shares issued when underwriters fully exercised their option to purchase extra shares.

Heartflow’s stock began trading on the Nasdaq Global Select Market on August 8 under the ticker symbol "HTFL." The IPO was managed by J.P. Morgan, Morgan Stanley and Piper Sandler as joint book-running managers, with Stifel and Canaccord Genuity serving as co-managers.

The company describes itself as the developer of Heartflow One, a non-invasive coronary care platform that provides patient insights throughout the CCTA pathway. According to the company’s statement, the AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis capabilities.

Heartflow claims its technology is supported by the ACC/AHA Chest Pain Guideline and has been used in the management of over 400,000 patients worldwide.

The announcement was made in a press release issued by the company.

In other recent news, Heartflow, Inc. has announced the pricing of its upsized initial public offering at $19 per share. The company is offering 16,666,667 shares of common stock. This move is expected to generate approximately $316.7 million in gross proceeds before accounting for underwriting discounts, commissions, and other expenses. This development marks a significant step for Heartflow as it seeks to raise capital in the public markets. The proceeds from the IPO will likely support the company’s ongoing operations and potential future expansions. This news follows a press release statement from Heartflow, highlighting the company’s focus on advancing its business objectives. Investors and market analysts will be closely watching how Heartflow utilizes the funds raised from this offering.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.